Wolverine Trading’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.11M | Buy |
+8,100
| New | +$1.97M | ﹤0.01% | 2133 |
|
|
2025
Q2 | – | Sell |
-22,700
| Closed | -$5.04M | – | 5700 |
|
|
2025
Q1 | $5.04M | Buy |
22,700
+13,800
| +155% | +$3.8M | 0.01% | 987 |
|
|
2024
Q4 | $2.93M | Sell |
8,900
-8,000
| -47% | -$2.52M | ﹤0.01% | 1640 |
|
|
2024
Q3 | $5.26M | Buy |
16,900
+4,600
| +37% | +$1.41M | 0.01% | 1012 |
|
|
2024
Q2 | $4.05M | Sell |
12,300
-1,200
| -9% | -$424K | ﹤0.01% | 1101 |
|
|
2024
Q1 | $5.34M | Buy |
13,500
+11,800
| +694% | +$4.36M | 0.01% | 982 |
|
|
2023
Q4 | $599K | Sell |
1,700
-10,700
| -86% | -$3.79M | ﹤0.01% | 2766 |
|
|
2023
Q3 | $4.65M | Buy |
12,400
+7,900
| +176% | +$3.06M | ﹤0.01% | 1051 |
|
|
2023
Q2 | $1.7M | Sell |
4,500
-1,800
| -29% | -$643K | ﹤0.01% | 1581 |
|
|
2023
Q1 | $2.15M | Buy |
6,300
+5,300
| +530% | +$1.55M | ﹤0.01% | 1325 |
|
|
2022
Q4 | $235K | Buy |
+1,000
| New | +$237K | ﹤0.01% | 2985 |
|
|
2022
Q3 | – | Sell |
-1,700
| Closed | -$509K | – | 5473 |
|
|
2022
Q2 | $509K | Sell |
1,700
-800
| -32% | -$260K | ﹤0.01% | 2531 |
|
|
2022
Q1 | $1.04M | Sell |
2,500
-700
| -22% | -$274K | ﹤0.01% | 2398 |
|
|
2021
Q4 | $1.51M | Sell |
3,200
-8,800
| -73% | -$3.79M | ﹤0.01% | 2159 |
|
|
2021
Q3 | $5.19M | Sell |
12,000
-400
| -3% | -$169K | 0.01% | 1273 |
|
|
2021
Q2 | $4.46M | Buy |
12,400
+300
| +2% | +$99.1K | 0.01% | 1246 |
|
|
2021
Q1 | $3.37M | Buy |
+12,100
| New | +$3.46M | 0.01% | 1436 |
|
|
2020
Q4 | – | Sell |
-2,300
| Closed | -$629K | – | 5581 |
|
|
2020
Q3 | $629K | Buy |
2,300
+800
| +53% | +$212K | ﹤0.01% | 2560 |
|
|
2020
Q2 | $330K | Sell |
1,500
-1,400
| -48% | -$275K | ﹤0.01% | 3215 |
|
|
2020
Q1 | $440K | Buy |
+2,900
| New | +$446K | ﹤0.01% | 2798 |
|
|
2019
Q4 | – | Sell |
-5,100
| Closed | -$718K | – | 5299 |
|
|
2019
Q3 | $718K | Sell |
5,100
-4,400
| -46% | -$606K | ﹤0.01% | 2256 |
|
|
2019
Q2 | $1.19M | Buy |
+9,500
| New | +$1.12M | ﹤0.01% | 1896 |
|
|
2019
Q1 | – | Sell |
-7,000
| Closed | -$674K | – | 5438 |
|
|
2018
Q4 | $674K | Buy |
+7,000
| New | +$760K | ﹤0.01% | 2353 |
|
|
2017
Q4 | – | Sell |
-2,500
| Closed | -$241K | – | 5597 |
|
|
2017
Q3 | $241K | Buy |
+2,500
| New | +$226K | ﹤0.01% | 3572 |
|
Other funds holding WST
Wolverine Trading's WST Position: Q2 2025 in Review
Wolverine Trading sold out of West Pharmaceutical (WST) in Q2 2025, closing a stake of 7,912 shares — an estimated $1.76M sold.
Wolverine Trading first reported a position in WST in Q2 2016 and held it in 16 quarters. The position peaked at $1.76M in Q1 2025. 730 funds tracked by Wall St. Rank hold WST as of Q2 2025.
- Wolverine Trading reported no remaining West Pharmaceutical position as of Q2 2025 after selling out during the quarter.
- Wolverine Trading sold 7,912 West Pharmaceutical shares in Q2 2025, an estimated $1.76M.
- Wolverine Trading first reported a position in West Pharmaceutical in Q2 2016 and held it in 16 quarters.
- Wolverine Trading's West Pharmaceutical position peaked at $1.76M in Q1 2025.
- 730 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2025.
Based on Wolverine Trading's 13F filing for Q2 2025, filed 18 Aug 2025.